Skip to content

Author

K. Nogami

We have 1 of 63 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Extended Half-Life Recombinant Factor VIII Conjugated with Modifying Substances Does Not Affect Fibrin Clot Formation or Stability in Haemophilia A Blood Samples.

Direct modification by PEGylation or IgG-Fc fusion to impart EHL characteristics preserves the functional properties of native FVIII, suggesting that PEGylation or Fc fusion do not impair its functional properties related to fibrin clot formation and stability.

N. Shimonishi, K. Nogami · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.